Nguyen Tuan — SEC insider filings

SEC reporting owner CIK 2063445. 5 insider filings on record with FilingPulse; latest filed 2026-10-07.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-03-31 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arbutus Biopharma Corp (ABUS)Chief Financial Officer5——10

Insider filings — Nguyen Tuan

FiledFormIssuerReported transactionsSource
2026-10-074Arbutus Biopharma Corp (ABUS)Disposition to issuer (D): 48,081 @ $5EDGAR
2026-09-234Arbutus Biopharma Corp (ABUS)Option exercise (M): 265,625 @ $3.49 · Option exercise (M): 27,475 @ $4.39 · Tax withholding (F): 206,637 @ $5.07 · Option exercise (M): 265,625 (derivative) @ $0 · Option exercise (M): 27,475 (derivative) @ $0EDGAR
2026-02-024Arbutus Biopharma Corp (ABUS)Grant/award (A): 73,500 @ $0 · Grant/award (A): 188,400 (derivative) @ $0EDGAR
2025-04-014/AArbutus Biopharma Corp (ABUS)Grant/award (A): 750,000 (derivative) @ $0EDGAR
2025-03-314Arbutus Biopharma Corp (ABUS)Grant/award (A): 750,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2063445 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs